急性间歇性炎与丹塞特龙相关
Olga Charnaya1, Elizabeth Goswami2
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ocharna1@jhmi.edu.
Pediatric nephrology (Berlin, Germany)
|June 2, 2025
概括
一名16岁的青少年在使用丹塞后经历了急性损伤. 药物停用后,功能得到改善,突出显示丹塞.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床药理学 临床药理学
背景情况:
- 急性损伤 (AKI) 可以呈现出各种不同的病因.
- 药物诱导的毒性是青少年健康的一个重大问题.
研究的目的:
- 报告一名16岁男性患有严重功能障碍的病例,可能与丹塞有关.
- 调查丹塞暴露与急性损伤之间的关联.
主要方法:
- 一个16岁的男性患有发作和严重功能障碍的病例报告.
- 在药物审查和停药后对功能进行临床观察.
- 分析患者的暴露史,包括丹塞和伊布洛芬.
主要成果:
- 患者呈现严重的功能障碍和稀释尿液.
- 在停止所有先前的药物治疗后,包括丹塞,功能显著改善.
- 功能障碍在接下来的一剂Ondansetron后复发,在停药后恢复正常.
结论:
- 在青少年中,Ondansetron可能与急性损伤有关.
- 对功能恢复至关重要的是迅速识别和撤销侵扰剂.
- 需要对丹塞的毒性潜力进行进一步的研究.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
330
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
330
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
462
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
462
Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Acute Kidney Injury II: Pathophysiology
101
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
101
Drugs for Treatment of Diarrhea-Predominant IBS
315
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
315


